Donor‐Specific Antibodies in Pediatric Intestinal and Multivisceral Transplantation: The Role of Liver and Human Leukocyte Antigen Mismatching. Issue 12 (4th December 2018)

• Record Type: Journal Article
• Authors: Talayero, Paloma; Ramos Boluda, Esther; Gómez Massa, Elena; Castro Panete, María José; Prieto Bozano, Gerardo; Hernández Oliveros, Francisco; López Santamaría, Manuel; Calvo Pulido, Jorge; Paz‐Artal, Estela; Mancebo, Esther
• Is Part Of: Liver transplantation. Volume 24:Issue 12(2018)
• Page Start: 1726
• Page End: 1735
• Publication Date: 2018-12-04
• Subjects: Liver -- Transplantation -- Periodicals; Liver -- Diseases -- Periodicals; Liver Transplantation -- Periodicals; Foie -- Greffe -- Périodiques; 617.5560592
• DOI: 10.1002/lt.25323
• Languages: English
• ISSNs: 1527-6465

Abstract

Abstract : Rejection is one of the most important drawbacks for graft and patient survival in intestinal and multivisceral transplantation. However, there is no consensus on the diagnostic criteria for humoral rejection, and the literature about the role of donor‐specific antibodies (DSA) on allograft outcome and the risk factors that contribute to their development is scant with contradictory results. The present study analyzes the role of DSA exclusively in a pediatric cohort of 43 transplants. Among our patients, 11.6% showed preformed DSA, but they did not correlate with more rejection or less allograft survival. Having previous transplants was the main sensitization factor with an odds ratio (OR) = 44.85 ( P = 0.001). In total, 16.3% of recipients developed de novo donor‐specific antibodies (dnDSA), mostly directed against human leukocyte antigen (HLA) class II, polyspecific and complement fixing. Additionally, the presence of dnDSA had a deleterious effect on graft rejection (hazard ratio [HR] = 11.00; P = 0.01) and survival (HR = 66.52; P < 0.001) in an observational period of 5 years after transplantation. The inclusion of the liver emerged as the main protective factor against dnDSA development with an OR = 0.07 ( P = 0.007). The analysis of HLA compatibility at the serological and epitope level with the computational tools HLAMatchmaker and PIRCHE revealed no association between HLA mismatching and dnDSA. In conclusion, this study performed in pediatric recipients shows the deleterious effect of dnDSA on intestinal transplantation supported by the complement‐fixing activity observed. Additionally, the liver inclusion in the allografts showed to be a protective factor against dnDSA generation.